Onswik is approved to improve glycemic control in adults with Type 2 diabetes and will be available in the United States in the coming months in two concentrations. No information is available on the list price.
|Articles|October 1, 2009
State of the Industry 2010: patient-centered medical homes through 2013
State of the Industry survey results
Advertisement
With so many stakeholders taking a long look at so many models, Edwina Rogers, executive director of the Patient-Centered Primary Care Collaborative, was surprised that most respondents (39.1%) predict that projects will spread only into a few small areas.
"I would say that's on the low side with all the activity going on," says Rogers.
Although many note medical homes can increase utilization, Rogers believes the evidence coming out of real-world applications supports the model's potential.
"It tackles the cost and quality issues, and it revamps the delivery system," she says. "It is a major component that is proven to work. We don't have any negative examples."
Advertisement
Related to this article
A meta-analysis of 13 trials and 969 patients saw some short-term reductions in cancer-related pain and anxiety, especially during procedures, when using virtual reality.
Chad Hatfield, Pharm.D., M.H.A., BCPS, vice president and chief pharmacy officer of UC Davis Health, says pharmacists are embedded in “nearly all specialties," with more than 150 holding board certification.
A new Spherix Global Insights survey shows providers want administrative support for prior authorization while patients prioritize access and affordability
8-year data show adjuvant Tagrisso boosts survival after surgery for EGFR-mutated NSCLC, reshaping early Lung Cancer care and adherence.
Sova, a clinical advisor for Employers Health, expects more employers to exclude GLP-1s for obesity but urges a look at coverage for specific cardiometabolic conditions.
Employers Health’s Alexis Sova says employers excluding GLP-1s now lean on weight management programs and direct-to-employer deals, not a hard cutoff.
Approximately two-thirds of Employers Health clients now exclude GLP-1s for obesity, up from a roughly even split at launch as cost drives coverage decisions.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Survey identifies what doctors and patients want from support programs
2
Virtual reality could become new treatment tool for cancer pain and anxiety, meta-analysis finds
3
Chad Hatfield, Pharm.D., on embedding pharmacists across specialties in the UC Davis Health System
4
Early-stage lung cancer patients on Tagrisso are living past 8 years
5